1-(9H-Fluoren-9-yl)-3,12-dioxo-2,7,10,16,19-pentaoxa-4,13-diazahenicosan-21-oic acid, 97%, 5g

2-{[(tert-butoxy)carbonyl]amino}-3-{1h-pyrrolo[2,3-b]pyridin-3-yl}propanoic acid, 98+%, 100mg

7-Bromo-2-chloro-quinoline, 96.0%, 5g

Methyl 2-fluoro-2-methylpropanoate, 95.0%, 25g

tert-Butyl (trans-2-hydroxycyclopentyl)carbamate, 95.0%, 5g

1-(2-{4-[(1E)-2-(2,5-dimethylphenyl)diazen-1-yl]-2,5-dimethylphenyl}hydrazin-1-ylidene)-1,2-dihydronaphthalen-2-one, 500g

Nonanal>95.0%(GC)25mL

4,4'-Thiobis(2-(tert-butyl)-5-methylphenol), 95.0%, 500g

3,5-Dichlorobenzenesulfonamide, 97.0%, 25g

(S)-4-Nitrophenyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate, 95.0%, 25g

(hexylsulfanyl)methanimidamide hydrobromide, 95.0%, 5g

4-Chloro-2-(pyridin-2-yl)pyrimidine, 95.0%, 5g

2,4-Dichlorobenzofuro[3,2-d]pyrimidine, 97%, 250mg